JP2014506563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506563A5 JP2014506563A5 JP2013549878A JP2013549878A JP2014506563A5 JP 2014506563 A5 JP2014506563 A5 JP 2014506563A5 JP 2013549878 A JP2013549878 A JP 2013549878A JP 2013549878 A JP2013549878 A JP 2013549878A JP 2014506563 A5 JP2014506563 A5 JP 2014506563A5
- Authority
- JP
- Japan
- Prior art keywords
- albumin
- composition
- gene therapy
- administered
- therapy vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1101167.3A GB201101167D0 (en) | 2011-01-22 | 2011-01-22 | Convection enhanced delivery apparatus and method |
| GB1101167.3 | 2011-01-22 | ||
| PCT/GB2012/000062 WO2012098367A1 (en) | 2011-01-22 | 2012-01-23 | Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (ced) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506563A JP2014506563A (ja) | 2014-03-17 |
| JP2014506563A5 true JP2014506563A5 (https=) | 2015-01-29 |
| JP6010047B2 JP6010047B2 (ja) | 2016-10-19 |
Family
ID=43769504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013549878A Expired - Fee Related JP6010047B2 (ja) | 2011-01-22 | 2012-01-23 | 対流強化送達（ｃｅｄ）による選択的複製性単純ヘルペスウイルスベクターの脳への送達 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8901077B2 (https=) |
| EP (1) | EP2665748A1 (https=) |
| JP (1) | JP6010047B2 (https=) |
| CN (1) | CN103328504A (https=) |
| GB (1) | GB201101167D0 (https=) |
| WO (1) | WO2012098367A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201204263D0 (en) * | 2012-03-12 | 2012-04-25 | Renishaw Plc | Giloma treatment |
| GB201308917D0 (en) * | 2013-05-17 | 2013-07-03 | Renishaw Plc | Delivery |
| US20220233716A1 (en) * | 2019-05-31 | 2022-07-28 | Avectas Limited | Methods of viral delivery to a population of cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585096A (en) * | 1994-06-23 | 1996-12-17 | Georgetown University | Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| DK2019683T4 (da) * | 2006-04-25 | 2022-08-29 | Univ California | Indgivelse af vækstfaktorer til behandling af CNS-lidelser |
-
2011
- 2011-01-22 GB GBGB1101167.3A patent/GB201101167D0/en not_active Ceased
-
2012
- 2012-01-23 WO PCT/GB2012/000062 patent/WO2012098367A1/en not_active Ceased
- 2012-01-23 JP JP2013549878A patent/JP6010047B2/ja not_active Expired - Fee Related
- 2012-01-23 EP EP12706076.2A patent/EP2665748A1/en not_active Withdrawn
- 2012-01-23 CN CN2012800060196A patent/CN103328504A/zh active Pending
- 2012-01-23 US US13/979,032 patent/US8901077B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3398616A3 (en) | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway | |
| EP3682875A3 (en) | Methods of treating pediatric metabolic syndrome | |
| WO2013101897A3 (en) | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | |
| HK1205156A1 (en) | Cyclodextrin-based polymers for therapeutic delivery | |
| JP2010280671A5 (https=) | ||
| JP2012041342A5 (https=) | ||
| WO2018157171A3 (en) | Compositions, articles of manufacture and methods related to dosing in cell therapy | |
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| JP2016517888A5 (https=) | ||
| BR112013027674A2 (pt) | "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha". | |
| JP2009173664A5 (https=) | ||
| EA201492292A1 (ru) | Препарат антител | |
| BR112013026363A2 (pt) | nanossuspensões de fármaco criodessecadas | |
| BR112014014262A2 (pt) | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. | |
| NZ598348A (en) | Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels | |
| MX2014009757A (es) | Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia. | |
| EP2595633A4 (en) | METHOD FOR INTRAVENOUS ADMINISTRATION OF GLYBURID AND OTHER MEDICAMENTS | |
| CA2915027A1 (en) | Compositions and methods for administration of vaccines against dengue virus | |
| EA201491702A1 (ru) | Оптимизированные терапевтические агенты для подкожного введения | |
| EP2682101A3 (en) | Inhalation Compositions Comprising Glucose Anhydrous | |
| EA201591188A1 (ru) | Доставка глатирамера ацетата через слизистую оболочку | |
| WO2012092305A3 (en) | Nanonized iron compositions and methods of use thereof | |
| EP2925352A4 (en) | HONESTICAL INVASIN FOR IMMUNIZATION, DIAGNOSIS AND CELL RELEASE | |
| EA201591415A1 (ru) | Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии | |
| JP2014506563A5 (https=) |